This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Bruker Daltonik Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Sandra Rauser - Innovator in Biochemical Methods
Introduction
Sandra Rauser is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biochemistry, particularly in the area of cancer research. Her innovative methods have the potential to enhance the understanding and treatment of various cancers.
Latest Patents
Sandra Rauser holds a patent for a method titled "Determining an expression status of human epidermal growth factor receptor 2 (HER2) in a biological sample." This method involves providing a sample from a subject and measuring the amounts of specific proteins in the sample. The proteins measured have molecular weights that are substantially equal to 4740, 8404, 8419, 8435, 8450, 8455, 8465, 8570, 8607, or 8626 atomic mass units. Additionally, the method includes measuring amounts of human cystein-rich intestinal protein 1 (CRIP1) and its variants, comparing these amounts to control amounts that determine the expression of HER2.
Career Highlights
Sandra Rauser is currently employed at Bruker Daltonik GmbH, where she continues to develop her innovative methods. Her work is crucial in advancing the understanding of HER2 expression, which is vital for cancer diagnostics and treatment.
Collaborations
Sandra collaborates with notable colleagues, including Sören-Oliver Deininger and Eckhard Belau. Their combined expertise contributes to the success of their research and innovations.
Conclusion
Sandra Rauser is a key figure in the field of biochemistry, with her patent offering valuable insights into cancer research. Her work at Bruker Daltonik GmbH and collaborations with esteemed colleagues further enhance her contributions to the scientific community.